Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17341
Country/Region: Malawi
Year: 2018
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: HHS/CDC
Total Funding: $5,671,540 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $322,743
Laboratory Infrastructure (HLAB) $1,551,894
Testing: HIV Testing and Counseling (HVCT) $292,500
Treatment: Adult Treatment (HTXS) $2,453,082
Treatment: Pediatric Treatment (PDTX) $1,051,321
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST <5, Unknown Sex, Negative 2019 85
HTS_TST 15-19, Female, Negative 2019 75
HTS_TST 15-19, Male, Negative 2019 250
HTS_TST 20-24, Female, Negative 2019 75
HTS_TST 20-24, Male, Negative 2019 250
HTS_TST 25-29, Female, Negative 2019 4,594
HTS_TST 25-29, Female, Negative 2019 380
HTS_TST 25-29, Female, Negative 2019 892
HTS_TST 25-29, Female, Negative 2019 1,097
HTS_TST 25-29, Female, Negative 2019 12,549
HTS_TST 25-29, Female, Negative 2019 50
HTS_TST 25-29, Female, Negative 2019 14
HTS_TST 25-29, Male, Negative 2019 3,821
HTS_TST 25-29, Male, Negative 2019 1,130
HTS_TST 25-29, Male, Negative 2019 1,000
HTS_TST 25-29, Male, Negative 2019 1,449
HTS_TST 25-29, Male, Negative 2019 93
HTS_TST 25-29, Male, Negative 2019 18
HTS_TST 30-34, Female, Negative 2019 4,135
HTS_TST 30-34, Female, Negative 2019 332
HTS_TST 30-34, Female, Negative 2019 803
HTS_TST 30-34, Female, Negative 2019 951
HTS_TST 30-34, Female, Negative 2019 4,690
HTS_TST 30-34, Female, Negative 2019 43
HTS_TST 30-34, Female, Negative 2019 8
HTS_TST 30-34, Male, Negative 2019 3,274
HTS_TST 30-34, Male, Negative 2019 969
HTS_TST 30-34, Male, Negative 2019 856
HTS_TST 30-34, Male, Negative 2019 1,266
HTS_TST 30-34, Male, Negative 2019 72
HTS_TST 30-34, Male, Negative 2019 14
HTS_TST 35-39, Female, Negative 2019 3,013
HTS_TST 35-39, Female, Negative 2019 244
HTS_TST 35-39, Female, Negative 2019 581
HTS_TST 35-39, Female, Negative 2019 724
HTS_TST 35-39, Female, Negative 2019 3,303
HTS_TST 35-39, Female, Negative 2019 24
HTS_TST 35-39, Female, Negative 2019 3
HTS_TST 35-39, Male, Negative 2019 2,799
HTS_TST 35-39, Male, Negative 2019 836
HTS_TST 35-39, Male, Negative 2019 733
HTS_TST 35-39, Male, Negative 2019 1,095
HTS_TST 35-39, Male, Negative 2019 63
HTS_TST 35-39, Male, Negative 2019 9
HTS_TST 40-49, Female, Negative 2019 4
HTS_TST 40-49, Female, Negative 2019 1,691
HTS_TST 40-49, Female, Negative 2019 119
HTS_TST 40-49, Female, Negative 2019 329
HTS_TST 40-49, Female, Negative 2019 526
HTS_TST 40-49, Female, Negative 2019 15,626
HTS_TST 40-49, Female, Negative 2019 7
HTS_TST 40-49, Male, Negative 2019 17
HTS_TST 40-49, Male, Negative 2019 3,605
HTS_TST 40-49, Male, Negative 2019 1,070
HTS_TST 40-49, Male, Negative 2019 946
HTS_TST 40-49, Male, Negative 2019 1,380
HTS_TST 40-49, Male, Negative 2019 90
HTS_TST 50+, Male, Negative 2019 4
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 200,316
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 3,547
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 5,578
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 8,862
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 14
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 171
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 34
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 32
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 926
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,219
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 926
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,219
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 187
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 42
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 420
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 82
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 80
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 1,648
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 2,464
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,648
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 2,464
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 7
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 176
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2019 676
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 5,570
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 1,232
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 1,195
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,843
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 3,478
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,869
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 3,511
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 138
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 259
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 4,599
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 37
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 102
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 37
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 102
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 348
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 2,852
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 619
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 605
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 8,041
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 14,958
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 8,041
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 14,958
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 149
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 702
HTS_TST_POS 15-19, Female, Positive 2019 1
HTS_TST_POS 15-19, Male, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 1
HTS_TST_POS 20-24, Male, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 225
HTS_TST_POS 25-29, Female, Positive 2019 36
HTS_TST_POS 25-29, Female, Positive 2019 25
HTS_TST_POS 25-29, Female, Positive 2019 27
HTS_TST_POS 25-29, Female, Positive 2019 298
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 85
HTS_TST_POS 25-29, Male, Positive 2019 77
HTS_TST_POS 25-29, Male, Positive 2019 7
HTS_TST_POS 25-29, Male, Positive 2019 13
HTS_TST_POS 30-34, Female, Positive 2019 280
HTS_TST_POS 30-34, Female, Positive 2019 47
HTS_TST_POS 30-34, Female, Positive 2019 34
HTS_TST_POS 30-34, Female, Positive 2019 31
HTS_TST_POS 30-34, Female, Positive 2019 91
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 251
HTS_TST_POS 30-34, Male, Positive 2019 206
HTS_TST_POS 30-34, Male, Positive 2019 48
HTS_TST_POS 30-34, Male, Positive 2019 60
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 260
HTS_TST_POS 35-39, Female, Positive 2019 45
HTS_TST_POS 35-39, Female, Positive 2019 31
HTS_TST_POS 35-39, Female, Positive 2019 30
HTS_TST_POS 35-39, Female, Positive 2019 54
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 267
HTS_TST_POS 35-39, Male, Positive 2019 215
HTS_TST_POS 35-39, Male, Positive 2019 54
HTS_TST_POS 35-39, Male, Positive 2019 63
HTS_TST_POS 35-39, Male, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 345
HTS_TST_POS 40-49, Female, Positive 2019 63
HTS_TST_POS 40-49, Female, Positive 2019 47
HTS_TST_POS 40-49, Female, Positive 2019 47
HTS_TST_POS 40-49, Female, Positive 2019 381
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Male, Positive 2019 2
HTS_TST_POS 40-49, Male, Positive 2019 531
HTS_TST_POS 40-49, Male, Positive 2019 436
HTS_TST_POS 40-49, Male, Positive 2019 142
HTS_TST_POS 40-49, Male, Positive 2019 141
HTS_TST_POS 40-49, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 61
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 119
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 197
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 124
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 146
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 124
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 146
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 88
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 88
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 106
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 74
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 57
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 76
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 58
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 495
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 401
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 495
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 401
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 26
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,878
PMTCT_ART New on ART 2019 1,260
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 3,138
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 57,465
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 2,168
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 535
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 2,703
PMTCT_EID Sum of Infant Age disaggregates 2019 2,703
PMTCT_STAT 25-29, Female 2019 19,629
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 679
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 18,572
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 446
PMTCT_STAT 30-34, Female 2019 3,616
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 106
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 3,410
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 63
PMTCT_STAT 35-39, Female 2019 738
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 6
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 694
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 2
PMTCT_STAT 40-49, Female 2019 89
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 86
PMTCT_STAT By Age (Numerator): : 15-19 2019 12,950
PMTCT_STAT By Age (Numerator): 10-14 2019 118
PMTCT_STAT By Age (Numerator): 20-24 2019 20,312
PMTCT_STAT By Age (Numerator): 50+ 2019 13
PMTCT_STAT By known positives: 15-19 2019 447
PMTCT_STAT By known positives: 20-24 2019 695
PMTCT_STAT By new negatives: 10-14 2019 109
PMTCT_STAT By new negatives: 15-19 2019 12,252
PMTCT_STAT By new negatives: 20-24 2019 19,126
PMTCT_STAT By new negatives: 50+ 2019 12
PMTCT_STAT By new positives: 15-19 2019 298
PMTCT_STAT By new positives: 20-24 2019 463
PMTCT_STAT Number of new ANC and L&D clients 2019 66,809
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 57,465
PMTCT_STAT_den 25-29, Female 2019 23,034
PMTCT_STAT_den 30-34, Female 2019 3,801
PMTCT_STAT_den 35-39, Female 2019 776
PMTCT_STAT_den 40-49, Female 2019 103
PMTCT_STAT_den By Age (Denominator): 10-14 2019 127
PMTCT_STAT_den By Age (Denominator): 15-19 2019 15,204
PMTCT_STAT_den By Age (Denominator): 20-24 2019 23,745
PMTCT_STAT_den By Age (Denominator): 50+ 2019 19
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 27
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 194
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 27
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 306
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 555
TB_PREV By Age/Sex (Numerator): <15, Female 2019 508
TB_PREV By Age/Sex (Numerator): <15, Male 2019 508
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 3,555
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 5,577
TB_PREV IPT, Life-long ART, Already, Positive 2019 1,016
TB_PREV IPT, Life-long ART, New, Positive 2019 9,132
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 10,148
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 11,276
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 562
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 562
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 3,950
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 6,202
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 1,126
TB_PREV_den IPT, Life-long ART, New, Positive 2019 10,150
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 35
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 251
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 35
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 395
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 716
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 728
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 36
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 253
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 36
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 403
TX_CURR 25-29, Female, Positive 2019 5,407
TX_CURR 25-29, Male, Positive 2019 1,285
TX_CURR 30-34, Female, Positive 2019 8,370
TX_CURR 30-34, Male, Positive 2019 2,852
TX_CURR 35-39, Female, Positive 2019 9,474
TX_CURR 35-39, Male, Positive 2019 4,682
TX_CURR 40-49, Female, Positive 2019 12,590
TX_CURR 40-49, Male, Positive 2019 9,728
TX_CURR Age/Sex: <1 2019 385
TX_CURR Age/Sex: 1-9 2019 3,521
TX_CURR Age/Sex: 10-14 Female 2019 1,794
TX_CURR Age/Sex: 10-14 Male 2019 1,665
TX_CURR Age/Sex: 15-19 Female 2019 1,308
TX_CURR Age/Sex: 15-19 Male 2019 1,278
TX_CURR Age/Sex: 20-24 Female 2019 3,277
TX_CURR Age/Sex: 20-24 Male 2019 1,172
TX_CURR Age/Sex: 50+ Female 2019 6,898
TX_CURR Age/Sex: 50+ Male 2019 7,211
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 82,897
TX_CURR Sum of Age/Sex disaggregations 2019 2,586
TX_NEW 25-29, Female, Positive 2019 582
TX_NEW 25-29, Male, Positive 2019 296
TX_NEW 30-34, Female, Positive 2019 704
TX_NEW 30-34, Male, Positive 2019 729
TX_NEW 35-39, Female, Positive 2019 685
TX_NEW 35-39, Male, Positive 2019 774
TX_NEW 40-49, Female, Positive 2019 1,020
TX_NEW 40-49, Male, Positive 2019 1,490
TX_NEW Breastfeeding status 2019 576
TX_NEW By Age/Sex: <1 2019 74
TX_NEW By Age/Sex: 1-9 2019 258
TX_NEW By Age/Sex: 10-14 Female 2019 23
TX_NEW By Age/Sex: 10-14 Male 2019 20
TX_NEW By Age/Sex: 15-19 Female 2019 988
TX_NEW By Age/Sex: 15-19 Male 2019 787
TX_NEW By Age/Sex: 20-24 Female 2019 1,212
TX_NEW By Age/Sex: 20-24 Male 2019 787
TX_NEW By Age/Sex: 50+ Female 2019 2
TX_NEW By Age/Sex: 50+ Male 2019 158
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 10,589
TX_NEW Pregnancy status 2019 2,155
TX_NEW Sum of Age/Sex disaggregates 2019 3,977
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 50,523
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 1,807
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 251
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 1,725
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 251
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 28,614
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 508
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 16,859
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 508
TX_PVLS_den Denominator: Indication: Routine 2019 49,009
TX_PVLS_den Denominator: Indication: Targeted 2019 1,514
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 679
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 676
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 6,198
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 5,154
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 12,707
TX_RET Numerator by Status: Breastfeeding 2019 388
TX_RET Numerator by Status: Pregnant 2019 202
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 12,823
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 715
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 712
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 6,204
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,192
TX_RET_den Denominator by Status: Breastfeeding 2019 390
TX_RET_den Denominator by Status: Pregnant 2019 203
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 81,572
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 4,068
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 4,068
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 28,546
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 44,890
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 48,945
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 32,627
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 81,572
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 72,655
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 803
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 8,077
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 37
Cross Cutting Budget Categories and Known Amounts Total: $607,257
Human Resources for Health $407,257
Renovation $200,000